Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1992 Mar;31(2):235-43.
doi: 10.1097/00004583-199203000-00009.

Growth deficits in children treated with desipramine: a controlled study

Affiliations
Comparative Study

Growth deficits in children treated with desipramine: a controlled study

T Spencer et al. J Am Acad Child Adolesc Psychiatry. 1992 Mar.

Abstract

Using multiple assessment methods, growth deficits in weight and height were examined in a clinical sample of children and adolescents with attention deficit hyperactivity disorder treated chronically (mean 14 months) with desipramine (DMI) and two comparison samples of children treated chronically with methylphenidate (MPH) and a not-treated group. Although there were statistically significant weight deficits in children treated with both DMI and MPH compared with normal controls, only those treated with MPH sustained height deficits that attained statistical significance. It appears that DMI may be an appropriate alternative for patients with stimulant-associated severe suppression of growth in height.

PubMed Disclaimer

Comment in

  • Growth deficits and desipramine.
    Holt KG. Holt KG. J Am Acad Child Adolesc Psychiatry. 1992 Nov;31(6):1167-8. doi: 10.1097/00004583-199211000-00031. J Am Acad Child Adolesc Psychiatry. 1992. PMID: 1429424 No abstract available.

Publication types